This project explores how the regulation of proteins in tumours can be achieved through delivery of inhibitors directly to cancer cells. This will lead to potential new therapeutic approaches to patients with cancer that doesn't respond to standard treatment.
Prof Andrew Scott, Dr Vinochani Pillay, A/Prof John Mariadason, A/Prof Niall Tebbutt
Cancer Council Research Grant
Ludwig Institute for Cancer Research
$100,000 per annum